KNSA vs GILD: Which Stock is Better?

Side-by-side comparison of Kiniksa Pharmaceuticals International Plc and Gilead Sciences Inc in 2026

Comparison Updated:

KNSA

Kiniksa Pharmaceuticals International Plc

$47.30

GILD

Gilead Sciences Inc

$139.03

Key Metrics Comparison

MetricKNSAGILDWinner
Market Cap$3.60B$172.51BGILD
P/E Ratio62.7720.50GILD
EPS (TTM)$0.75$6.78GILD
Revenue Growth0.7%0.0%KNSA
Gross Margin54.7%78.8%GILD

Analyze KNSA

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KNSA or GILD a better investment?

Comparing KNSA and GILD: Kiniksa Pharmaceuticals International Plc has a market cap of $3.60B while Gilead Sciences Inc has $172.51B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KNSA and GILD?

KNSA (Kiniksa Pharmaceuticals International Plc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KNSA or GILD?

Based on P/E ratios, GILD trades at a lower multiple (20.5x vs 62.8x).

Which is growing faster: KNSA or GILD?

KNSA has higher revenue growth at 0.7% vs 0.0% for GILD.

Which company is more profitable: KNSA or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 54.7% for KNSA.

Which is the larger company: KNSA or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $172.51B compared to $3.60B for KNSA.

Should I buy KNSA or GILD in 2026?

Both KNSA and GILD have investment merit. KNSA trades at $47.30 while GILD trades at $139.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KNSA and GILD stock?

Key differences: Market Cap ($3.60B vs $172.51B), P/E Ratio (62.8x vs 20.5x), Revenue Growth (0.7% vs 0.0%), Gross Margin (54.7% vs 78.8%).

Popular Stock Comparisons